Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
197
datasets available to search
ShareScore release 0.7.1
Dataset results
197 results for “BCMA”
A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04601935. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
ClinicalTrials.gov study NCT06794008. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03266692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma
ClinicalTrials.gov study NCT03711864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia
ClinicalTrials.gov study NCT05979363. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03380039. IPD Sharing: NO. Countries: 1. Publications: 0.
Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma
ClinicalTrials.gov study NCT07353554. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03767725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
ClinicalTrials.gov study NCT07392528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06581640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
ClinicalTrials.gov study NCT04162353. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
ClinicalTrials.gov study NCT06548607. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of the Safety and Efficacy of BCMA CAR-NK
ClinicalTrials.gov study NCT05652530. IPD Sharing: NO. Countries: 1. Publications: 0.
Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
ClinicalTrials.gov study NCT07109323. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04714827. IPD Sharing: YES. Countries: 1. Publications: 0.
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
ClinicalTrials.gov study NCT07003555. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
ClinicalTrials.gov study NCT03741127. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04162119. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma
ClinicalTrials.gov study NCT03492268. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT
ClinicalTrials.gov study NCT06963866. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.